contact us

Who's Online

We have 104 guests and no members online

Background:

The Ethiopia Field Epidemiology Training Program (EFETP), African Field Epidemiology Network (AFENET), and the Training Programs in Epidemiology and Public Health Interventions Network (TEPHINET) are hosting the 5th AFENET Scientific Conference in Addis Ababa, Ethiopia from 17 to 22 November 2013 with the conference theme of “Addressing Public Health Priorities in Africa through FELTPs”.

In relation to this, the Ethiopian Health and Nutrition Research Institute (EHNRI), invites interested researchers to submit their abstract that will be presented on the 5th AFENET conference.

It is required that the abstracts focus on investigation of diseases of public health importance, mostly outbreak related diseases. Due to the fact that, some of the diseases investigations are approached using One Health Concept, the abstract is also required to consider the one health approach.

Five best abstracts, that will be selected based on the sited selection criteria will be presented during the conference as part of sharing Ethiopian’s experience in the area of field epidemiology. Conference participation fee for the presenters of the selected five abstracts will covered by the EHNRI.

Submission Procedures and Deadline

Abstract submission: Abstracts should be E-mailed to This email address is being protected from spambots. You need JavaScript enabled to view it.. Hard copy submissions will not be accepted.

Deadline for final abstract submission: 15 October, 2013

Structure of Abstracts

The abstract should not exceed 350 words. This count includes the subheadings of the structured abstract but does not include the title, author list and their addressees or key words.

Abstracts must include the following sections:

  • Introduction/Background
  • Methods
  • Results
  • Conclusion

Note:
Changes cannot be made to the final abstract after it is submitted. If however your abstract is accepted and significant changes have been made after submission of the abstract, please highlight the changes in your presentation.

Formatting

  • Text should be left aligned.
  • Use font Times New Roman, size 12, 1.5 spacing.
  • Each subheading should be in bold font, and followed by colon.
  • Do not include any tables or graphs in the abstract.
  • Avoid abbreviations; where used, mention them in full the first time they appear.
  • Use italics for scientific names.

Abstract title

  • The title should be descriptive but concise.
  • Avoid subtitles if possible.
  • Write the title in sentence case and only capitalize proper nouns and scientific names where appropriate e.g.Plasmodium falciparum
  • Do NOT use abbreviations or acronyms in the abstract title

Authors

  • First author: Provide first name, initials of the middle name (if any), and the last name e.g. David W. Meyers
  • Co-authors: List each co-author in order of contribution by typing their first and middle names as initials followed by their last name in full (e.g. W. Grisham, M. S. Pollock)
  • Provide the organizational affiliations of the first author and all co-authors
  • Indicate the corresponding author with an asterix* and provide their email address and telephone number plus their alternate contacts
  • Provide the email address and telephone number of the first author if the latter is not the corresponding author

Evaluation Criteria

Each abstract will be evaluated by three independent reviewers according to the following criteria:

  • Background and rationale of the study
  • Appropriateness of methods
  • Presentation of results
  • Conclusions and interpretations of results
  • Public health significance
  • Overall clarity of the abstract

Notification of abstract review outcome: Notification of accepted abstracts will be notified till 30th October 2013.